FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

FIRST CHECK HOME DRUG TEST FOR MDMA (ECSTASY)

K Number: K020869 · Decision Jun 11, 2002
Classifications
1
FEI Numbers
96
Registration Numbers
96
Same Product Code
224
Applicant Total
5
Review Days
85

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
FIRST CHECK HOME DRUG TEST FOR MDMA (ECSTASY)
K Number
K020869
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3100
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Worldwide Medical Corp.
Date Received
March 18, 2002
Decision Date
June 11, 2002
Product Code
DKZ
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DKZ Enzyme Immunoassay, Amphetamine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DKZ), ordered by most recent decision date.

View all

Other Clearances by Worldwide Medical Corp.

K Number Device Name
K993852 FIRST CHECK HOME DRUG TEST PANEL 4
K994138 FIRST CHECK HOME DRUG TEST PANEL 3
K993663 FIRST CHECK HOME DRUG TEST (THC)
K994139 FIRST CHECK HOME DRUG TEST PANEL 2